Elite in Keratitis-Ichthyosis-Deafness Syndrome

C Y. Cheng

No. 28, Xianning West Road, 
Xi'an, CN 
Elite in Keratitis-Ichthyosis-Deafness Syndrome
No. 28, Xianning West Road, 
Xi'an, CN 
OverviewLocationsClinical Research

Overview

C Cheng practices in Xi'an, China. Cheng is rated as an Elite expert by MediFind in the treatment of Keratitis-Ichthyosis-Deafness Syndrome. Their top areas of expertise are Keratitis-Ichthyosis-Deafness Syndrome, Acute Lymphoblastic Leukemia (ALL), Kienbock's Disease, Osteotomy, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 794 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Keratitis-Ichthyosis-Deafness Syndrome.

Locations

No. 28, Xianning West Road, Xi'an, 710049, China
Other Locations
No. 155. Hanzhong Road, Nanjing, 210029, China
Wenhua Road 103, Shenyang, China
No. 76, Yanta West Street, #54, Xi'an, 710061, China
127 Dongming Road, Zhengzhou, China
No. 100 Kexue Avenue, Zhengzhou, 450001, China
100 Kexue Avenue, Zhengzhou, 450001, China
Union Hospital, Wuhan, 430022, China
No. 45, Taizhou Road, Yangzhou, China
No. 321 Zhongshan Road, Nanjing, 210008, China
No. 1, Shanyuan Street, Haidian, 100081, China
225 Changhai Road, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

794 Total Publications

CRIP1 exacerbates osteoarthritis progression by recruiting UBE3A to induce the ubiquitination-mediated degradation of MFGE8.
CRIP1 exacerbates osteoarthritis progression by recruiting UBE3A to induce the ubiquitination-mediated degradation of MFGE8.
Journal: Biochemical pharmacology
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cheng's expertise for a condition
ConditionClose
View All 22 Advanced Conditions
View All 154 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile